Research News and Research

RSS

Drivers with Parkinson's disease at greater risk of crashes on foggy days

Drivers with mild to moderate Parkinson's disease may be at higher risk of crashes on foggy days and other times of low visibility. The research, involving a driving simulation test, is published in the October 6, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

6 Oct 2009

New journal on cancer biology and genetics

SAGE announces Genes & Cancer, a monthly journal edited by Dr. Prem Reddy, founder and previous Editor-in-Chief of the prestigious and highly-ranked Oncogene.

6 Oct 2009

Butler Hospital leads clinical study for effectiveness and safety of DBS for OCD

Butler Hospital in Providence, R.I., is leading a clinical study evaluating the effectiveness and safety of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD).

6 Oct 2009

Eat strawberries to improve cholesterol levels

According to a new study published in the October 2009 issue of Nutrition Journal, women with metabolic syndrome had reduced total cholesterol levels - including LDL - after a brief period of daily consumption of a strawberry-based beverage.

6 Oct 2009

$16 million federal stimulus funds for cancer research projects

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

6 Oct 2009

More efforts needed to present breast reconstruction options to all patients: Study

Latinas who spoke little English were less likely to undergo reconstruction surgery after a mastectomy for breast cancer, according to a study from researchers at the University of Michigan Comprehensive Cancer Center.

6 Oct 2009

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

As the first recipients of the H1N1 vaccine are vaccinated, more than half of Americans surveyed (52 percent) do not believe the H1N1 virus, or Swine Flu, will have a major impact in the United States compared to 44 percent who believe it will, according to the results of a new Deloitte Center for Health Solutions survey.

6 Oct 2009

Pomegranate juice beneficial for patients with elevated cardiovascular disease risk factors: Study

According to a clinical study released in The American Journal of Cardiology, a daily serving of POM Wonderful 100% Pomegranate Juice may decrease the progression of arterial plaque in patients with elevated cardiovascular disease risk factors. The study was intended to see if POM Wonderful 100% Pomegranate Juice may slow the progression of intima-media thickness of the carotid artery (CIMT) in patients with moderate coronary heart disease risk.

6 Oct 2009

Guided Therapeutics awarded $2.5M NCI grant for marketing LightTouch technology

Guided Therapeutics, Inc. today announced that it was awarded a $2.5 million matching grant by the National Cancer Institute (NCI) to bring to market and expand the array features for its LightTouch™ non-invasive cervical cancer detection technology. The award provides resources to complete the regulatory process and begin manufacturing ramp up for the device and single-patient-use disposable.

6 Oct 2009

Antibiotic minocycline may be used for treatment of strokes: Study

The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.

6 Oct 2009

ALS patients' bone marrow cells capable of differentiating into nerve-supporting cells

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that bone marrow cells taken from ALS patients were capable of differentiating into nerve-supporting cells.

5 Oct 2009

$40B needed to 'dramatically' reduce millions of child deaths annually, report says

Two million infants die within 24 hours of birth each year and almost nine million children died before the age of 5 in 2008, according to a report by Save the Children, which says it would take $40 billion annually to "dramatically" cut these numbers, Agence France-Presse reports (Mohiuddin, 10/5).

5 Oct 2009

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

Uncontrolled maternal asthma during pregnancy increases the likelihood of the child developing asthma

Expectant mothers who eschew asthma treatment during pregnancy heighten the risk transmitting the condition to their offspring, according to one of the largest studies of its kind published in the European Respiratory Journal.

5 Oct 2009

NC State researchers help design affordable sanitary pads from local, organic materials

For most American women, their "time of the month" is seen as a hindrance to daily life. In impoverished and developing countries, however, monthly periods are a major cause for concern among women. The lack of affordable, quality sanitary pads results in females missing up to 50 days of school annually - thereby compromising their educational and professional potential.

5 Oct 2009

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.

5 Oct 2009

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Bristol-Myers Squibb Company and AstraZeneca announced today that the European Commission has granted marketing authorisation for ONGLYZATM in the 27 countries of the European Union.

5 Oct 2009

Challenges surround the calculation of costs associated with illegal immigrant care

PhillyBurbs.com examines the cost of caring for undocumented immigrants and whether it really is cheaper to exclude them under a health care overhaul. Despite widespread support for requiring people to prove their citizenship to receive government health benefits, PhillyBurbs.com reports: "Public health and immigration experts worry excluding undocumented immigrants would put everyone at risk, hamper attempts to prevent the spread of disease and lead to an increase in health care spending."

5 Oct 2009

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Las Vegas-based Endogenous Stem Cells Activators Inc. (ESAI) announced today that it will award a $1.3 million grant to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LABioMed) for pre-clinical studies aimed at activating penile endogenous (adult) stem cells with the company's drug, KRONOS IV.

5 Oct 2009

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.

5 Oct 2009

Research News and Research

Drivers with Parkinson's disease at greater risk of crashes on foggy days

New journal on cancer biology and genetics

Butler Hospital leads clinical study for effectiveness and safety of DBS for OCD

Eat strawberries to improve cholesterol levels

$16 million federal stimulus funds for cancer research projects

More efforts needed to present breast reconstruction options to all patients: Study

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

Pomegranate juice beneficial for patients with elevated cardiovascular disease risk factors: Study

Guided Therapeutics awarded $2.5M NCI grant for marketing LightTouch technology

Antibiotic minocycline may be used for treatment of strokes: Study

ALS patients' bone marrow cells capable of differentiating into nerve-supporting cells

$40B needed to 'dramatically' reduce millions of child deaths annually, report says

MSF calls on drug companies to pool HIV patents

Uncontrolled maternal asthma during pregnancy increases the likelihood of the child developing asthma

NC State researchers help design affordable sanitary pads from local, organic materials

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Challenges surround the calculation of costs associated with illegal immigrant care

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News